Journal

UKCA remains available, but permanent CE recognition changes its commercial role. A practical analysis of choice, competition and British regulatory strategy.

The UK has confirmed long-term CE recognition. What changes for clinical AI, what still requires MHRA registration, and why NHS adoption remains separate.

Explore practical alternatives to Standard Medicine, including iatroX, AMBOSS, UpToDate Expert AI, OpenEvidence, Dyna AI and Heidi Evidence, matched to clinical tasks.

Understand where Standard Medicine, Heidi Evidence and iatroX fit in a doctor's day, from medical search and documentation to focused learning and clinical practice.

How UK clinicians can assess Standard Medicine's European focus against NHS needs, national guidance and the broader clinical learning features of iatroX.

Practical ways to reduce study friction, contain review workloads and vary medical revision, alongside appropriate university support rather than promises of an ADHD cure.

Separate clinical applications, cloud operation and model development when assessing European healthcare AI, with Tandem, Scaleway and Mistral as distinct examples.

Explain an AI scribe without vague sovereignty assurances: what it captures, who reviews the output, how patients can object and which processing details need verification.

A fictional clinic outage shows how to keep documentation, clinical decisions and unfinished tasks under control when an AI service becomes unavailable.

A practical change-control approach for clinical AI: identify what changed, test the affected workflow, communicate limitations and plan a proportionate response to regression.

Twelve practical supplier questions covering scope, processing, access, clinical evidence, model changes, downtime, exit and the complete cost of sovereign clinical AI.

European ownership and hosting are not complete NHS data-governance answers. Follow the legal entities, processing stages, remote access and transfer arrangements.